Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,793 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
Marston NA, Bergmark BA, Alexander VJ, et al. · N Engl J Med · 2026Clinical Trial, Phase III, Multicenter Study
- Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis.
Ballena-Caicedo J, Zuzunaga-Montoya FE, Loayza-Castro JA, et al. · J Health Popul Nutr · 2025Systematic Review, Meta-Analysis
- Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial.
Gaudet D, Pall D, Watts GF, et al. · JAMA Cardiol · 2024Randomized Controlled Trial, Clinical Trial, Phase II
- Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
Bergmark BA, Marston NA, Prohaska TA, et al. · N Engl J Med · 2025Randomized Controlled Trial, Multicenter Study
- [Not Available].
Mehran L, Amouzegar A, Rahimabad PK, et al. · Horm Metab Res · 2017Randomized Controlled Trial
- Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
Bergmark BA, Marston NA, Prohaska TA, et al. · N Engl J Med · 2024Randomized Controlled Trial, Multicenter Study
- Epidemiology of hypertriglyceridaemia.
Brotons C, Moral I, González J, et al. · Clin Investig Arterioscler · 2021Meta-Analysis
- Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials.
Wycherley TP, Moran LJ, Clifton PM, et al. · Am J Clin Nutr · 2012Meta-Analysis, Research Support, Non-U.S. Gov't
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
Lu J, Liu R, Ren H, et al. · Med · 2025Clinical Trial, Phase IV, Multicenter Study
- Novel agents for treating severe hypertriglyceridemia.
Wierzbicki AS · Med · 2024Randomized Controlled Trial
- Global burden and characterization of hypertriglyceridemia-induced acute pancreatitis: results from a systematic review and a multi-center cohort study.
Fan Z, Zhang Y, Li J, et al. · Sci China Life Sci · 2025Meta-Analysis, Multicenter Study
- Itacitinib Population Pharmacokinetics and Exposure-Response in Patients With Acute Graft-Versus-Host Disease.
Chen X, Xun Z, Yuska B, et al. · J Clin Pharmacol · 2023Randomized Controlled Trial, Clinical Trial, Phase III
- Chinese herbal medicines for hypertriglyceridaemia.
Liu ZL, Li GQ, Bensoussan A, et al. · Cochrane Database Syst Rev · 2013Research Support, Non-U.S. Gov't, Systematic Review
- Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.
Mozaffarian D, Maki KC, Bays HE, et al. · JAMA Netw Open · 2022Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis.
Kamrul-Hasan ABM, Dutta D, Nagendra L, et al. · Endocr Pract · 2024Systematic Review, Meta-Analysis
- Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study.
Sun Y, Wu C, Xin G, et al. · Hepatology · 2026Randomized Controlled Trial, Clinical Trial, Phase II
- Association of dietary phytochemical index with cardiometabolic risk factors.
Mehranfar S, Jalilpiran Y, Ejtahed HS, et al. · Int J Vitam Nutr Res · 2023Systematic Review, Meta-Analysis
- The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.
Bhatt DL, Bays HE, Miller M, et al. · Nat Med · 2023Randomized Controlled Trial, Clinical Trial, Phase II
- Recurrence rates and risk factors for recurrence after first episode of acute pancreatitis: A systematic review and meta-analysis.
Li S, Gao L, Gong H, et al. · Eur J Intern Med · 2023Meta-Analysis, Systematic Review
- Plasmapheresis compared with conventional treatment for hypertriglyceridemia-induced acute pancreatitis: A systematic review and meta-analysis.
Yan LH, Hu XH, Chen RX, et al. · J Clin Apher · 2023Meta-Analysis, Systematic Review
- Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
Lawitz EJ, Bhandari BR, Ruane PJ, et al. · Clin Gastroenterol Hepatol · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Insulin or blood purification treatment for hypertriglyceridaemia-associated acute pancreatitis: A systematic review and meta-analysis.
He W, Cai W, Yang X, et al. · Pancreatology · 2022Meta-Analysis, Systematic Review
- Efficacy and safety of olezarsen in patients with vs without baseline fibrate use.
Wang AZ, Alexander VJ, Prohaska TA, et al. · J Clin Lipidol · 2026Clinical Trial, Phase III, Randomized Controlled Trial
- Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
Gutierrez JA, Liu W, Perez S, et al. · Mol Metab · 2021Clinical Trial, Phase I, Randomized Controlled Trial
- Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis.
Zhong L, Liu J, Liu S, et al. · Front Endocrinol (Lausanne) · 2023Meta-Analysis, Systematic Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.